Key points are not available for this paper at this time.
Serum NfL holds promise as a biomarker for monitoring primary and secondary neuroaxonal injury after IS and for predicting functional outcome.
Share your take
Add a clinician perspective alongside expert commentary.
Tiedt et al. (2018) studied this question.